629 related articles for article (PubMed ID: 25939522)
1. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
Raychaudhuri SK; Saxena A; Raychaudhuri SP
Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
[TBL] [Abstract][Full Text] [Related]
2. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-17 in psoriasis and psoriatic arthritis.
Raychaudhuri SP
Clin Rev Allergy Immunol; 2013 Apr; 44(2):183-93. PubMed ID: 22362575
[TBL] [Abstract][Full Text] [Related]
4. IL-23/IL-17 axis in spondyloarthritis-bench to bedside.
Raychaudhuri SP; Raychaudhuri SK
Clin Rheumatol; 2016 Jun; 35(6):1437-41. PubMed ID: 27075462
[TBL] [Abstract][Full Text] [Related]
5. Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis.
Cauli A; Mathieu A
J Rheumatol Suppl; 2012 Jul; 89():15-8. PubMed ID: 22751583
[TBL] [Abstract][Full Text] [Related]
6. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
7. Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data.
Sakkas LI; Bogdanos DP
Autoimmun Rev; 2017 Jan; 16(1):10-15. PubMed ID: 27666819
[TBL] [Abstract][Full Text] [Related]
8. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
9. Th17 and Th22 cells in psoriatic arthritis and psoriasis.
Benham H; Norris P; Goodall J; Wechalekar MD; FitzGerald O; Szentpetery A; Smith M; Thomas R; Gaston H
Arthritis Res Ther; 2013 Sep; 15(5):R136. PubMed ID: 24286492
[TBL] [Abstract][Full Text] [Related]
10. Bone remodeling in psoriasis and psoriatic arthritis: an update.
Paine A; Ritchlin C
Curr Opin Rheumatol; 2016 Jan; 28(1):66-75. PubMed ID: 26555451
[TBL] [Abstract][Full Text] [Related]
11. Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.
Leijten EF; van Kempen TS; Olde Nordkamp MA; Pouw JN; Kleinrensink NJ; Vincken NL; Mertens J; Balak DMW; Verhagen FH; Hartgring SA; Lubberts E; Tekstra J; Pandit A; Radstake TR; Boes M
Arthritis Rheumatol; 2021 Jul; 73(7):1220-1232. PubMed ID: 33452865
[TBL] [Abstract][Full Text] [Related]
12. IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
Baeten D; Adamopoulos IE
Front Immunol; 2020; 11():623874. PubMed ID: 33679714
[TBL] [Abstract][Full Text] [Related]
13. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
Melis L; Vandooren B; Kruithof E; Jacques P; De Vos M; Mielants H; Verbruggen G; De Keyser F; Elewaut D
Ann Rheum Dis; 2010 Mar; 69(3):618-23. PubMed ID: 19196728
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
Mease PJ
Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
[TBL] [Abstract][Full Text] [Related]
15. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
Torres T; Faria R
Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
[TBL] [Abstract][Full Text] [Related]
16. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
17. Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis.
Steel KJA; Srenathan U; Ridley M; Durham LE; Wu SY; Ryan SE; Hughes CD; Chan E; Kirkham BW; Taams LS
Arthritis Rheumatol; 2020 Mar; 72(3):435-447. PubMed ID: 31677365
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.
Hammitzsch A; Ossadnik A; Bachmann Q; Merwald-Fraenk H; Lorenz G; Witt M; Wiesent F; Mühlhofer H; Simone D; Bowness P; Heemann U; Arbogast M; Moog P; Schmaderer C
Front Immunol; 2024; 15():1355824. PubMed ID: 38799447
[TBL] [Abstract][Full Text] [Related]
19. Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.
Yang L; Fanok MH; Mediero-Munoz A; Fogli LK; Corciulo C; Abdollahi S; Cronstein BN; Scher JU; Koralov SB
Arthritis Rheumatol; 2018 Jun; 70(6):855-867. PubMed ID: 29439292
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases.
Akitsu A; Iwakura Y
Immunology; 2018 Dec; 155(4):418-426. PubMed ID: 30133701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
